GlassScriptPhysician profile
Sonya M Soliman
NPI 1912140401
$685.13
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $98.17 · 2020: $183 · 2021: $348 · 2022: $56.05.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $128.27 | 2020-2021 | |
| Biohaven Pharmaceuticals, INC. | $89.47 | 2020-2021 | |
| Abbvie INC. | $88.78 | 2021-2022 | |
| Ucb, INC. | $62.85 | 2019-2021 | |
| Ge Healthcare | $56.33 | 2021-2022 | |
| Alexion Pharmaceuticals, INC. | $50.15 | 2019-2021 | |
| Sk Life Science, INC. | $43.10 | 2020-2021 | |
| Sunovion Pharmaceuticals INC. | $37.50 | 2021 | |
| Lundbeck LLC | $27.43 | 2021-2022 | |
| Greenwich Biosciences, INC. | $25.54 | 2021 | |
| Acorda Therapeutics, INC | $21.51 | 2021 | |
| Supernus Pharmaceuticals, INC. | $18.68 | 2019 | |
| Allergan, INC. | $12.67 | 2020 | |
| Eisai INC. | $11.64 | 2021 | |
| Avanir Pharmaceuticals, INC. | $11.21 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sonya Soliman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.